Ampersand Wants to Add $400 Million

Wade Roush7/31/08

Wellesley, MA-based private equity firm Ampersand Ventures, which invests in pharmaceutical, medical device, manufacturing, and enterprise software companies, has embarked on fundraising for a new fund targeted at $400 million, according to a report today at PE Hub. It’s been two years since the firm raised its current $212 million fund.

Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @